- Conditions: Cataract; Inflammation; Surgery
Interventions: Drug: Mapracorat; Drug: Placebo
Sponsors: Bausch & Lomb, Inc.; Bausch & Lomb, Inc.
Not yet recruiting - verified May 2012 - Conditions: Cataract; Inflammation; Surgery
Interventions: Drug: Mapracorat; Drug: Vehicle
Sponsors: Bausch & Lomb, Inc.; Bausch & Lomb, Inc.
Not yet recruiting - verified May 2012 - Conditions: Keratoconjunctivitis Due to Adenovirus; Viral Shedding
Interventions: Drug: Zirgan; Drug: genteal gel
Sponsors: Lifelong Vision Foundation; Lifelong Vision Foundation; Bausch & Lomb, Inc.
Recruiting - verified February 2012 - Condition: Macular Edema
Intervention: Procedure: Use of intraoperative filters in vitrectomy
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland; Clinical Trial Unit, University Hospital Basel, Switzerland; University of Pittsburgh; Ludwig-Maximilians - University of Munich; General Hospital Linz; Medical University of Graz
Recruiting - verified December 2011 - Condition: Cataract
Interventions: Drug: Loteprednol etabonate; Drug: Prednisolones acetate
Sponsors: Bausch & Lomb, Inc.; Bausch & Lomb, Inc.
Not yet recruiting - verified November 2011 - Condition: Blepharitis
Interventions: Drug: Erythromycin; Drug: Besifloxocin
Sponsors: John, George, M.D.; John, George, M.D.; Bausch & Lomb, Inc.
Completed - verified November 2011 - Conditions: Corneal Health; Cataract Surgery
Interventions: Drug: besivance; Drug: vigamox
Sponsors: Ophthalmology Consultants, Ltd.; Ophthalmology Consultants, Ltd.; Ophthalmology Associates, St Louis; Bausch & Lomb, Inc.
Completed - verified December 2010 - Conditions: Conjunctivitis, Seasonal Allergic; Conjunctivitis, Giant Papillary; Inflammation
Intervention: Drug: Loteprednol Etabonate
Sponsors: Bausch & Lomb, Inc.; Bausch & Lomb, Inc.
Recruiting - verified March 2012 - Condition: Seasonal Allergic Conjunctivitis
Interventions: Drug: Loteprednol etabonate 0.2%; Drug: Olopatadine 0.1%
Sponsors: Bausch & Lomb, Inc.; Bausch & Lomb, Inc.
Completed - verified February 2012 - Condition: Congenital Nasolacrimal Duct Obstruction
Interventions: Drug: Besifloxacin; Drug: polymyxin b/trimethoprim - ophthalmic
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey; Bausch & Lomb, Inc.
Recruiting - verified September 2011 - Condition: Keratoconus
Intervention: Device: KeraSoft IC Soft Contact Lenses
Sponsors: Bausch & Lomb, Inc.; Bausch & Lomb, Inc.
Active, not recruiting - verified September 2011 - Condition: Myopia
Interventions: Device: PureVision2 HD contact lenses; Other: Spectacles
Sponsors: Bausch & Lomb, Inc.; Bausch & Lomb, Inc.
Completed - verified March 2012 - Conditions: Meibomian Gland Dysfunction; Posterior Blepharitis
Interventions: Drug: Loteprednol/tobramycin; Drug: Loteprednol; Drug: Bausch + Lomb Advanced Eye Relief Lubricant Eye Drops
Sponsors: Massachusetts Eye and Ear Infirmary; Massachusetts Eye and Ear Infirmary; Bausch & Lomb, Inc.
Recruiting - verified October 2011 - Condition: Dry Eye
Interventions: Drug: B & L Soothe Lubricant Eye Drops; Drug: Liposic EDO; Drug: OcuFresh Eye Wash
Sponsors: University of Rochester; University of Rochester; Bausch & Lomb, Inc.
Recruiting - verified May 2012 - Condition: Healthy
Interventions: Device: All-in-One Light multipurpose; Device: Aquify care
Sponsors: Sauflon Pharmaceuticals Ltd; Sauflon Pharmaceuticals Ltd
Completed - verified July 2011
 |
Bausch & Lomb - Database of Clinical Trials by Pharmaceutical Companies |
